Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience

Importance: Passive antibody transfer is a longstanding treatment strategy for infectious diseases that involve the respiratory system. In this context, human convalescent plasma has been used to treat coronavirus disease 2019 (COVID-19), but the efficacy remains uncertain. Objective: To explore pot...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:medRxiv
Main Authors: Joyner, Michael J, Senefeld, Jonathon W, Klassen, Stephen A, Mills, John R, Johnson, Patrick W, Theel, Elitza S, Wiggins, Chad C, Bruno, Katelyn A, Klompas, Allan M, Lesser, Elizabeth R, Kunze, Katie L, Sexton, Matthew A, Diaz Soto, Juan C, Baker, Sarah E, Shepherd, John R.A., van Helmond, Noud, van Buskirk, Camille M, Winters, Jeffrey L, Stubbs, James R, Rea, Robert F, Hodge, David O, Herasevich, Vitaly, Whelan, Emily R, Clayburn, Andrew J, Larson, Kathryn F, Ripoll, Juan G, Andersen, Kylie J, Buras, Matthew R, Vogt, Matthew N.P., Dennis, Joshua J, Regimbal, Riley J, Bauer, Philippe R, Blair, Janis E, Paneth, Nigel S, Fairweather, DeLisa, Wright, R. Scott, Carter, Rickey E, Casadevall, Arturo
פורמט: Artigo
שפה:Inglês
יצא לאור: Cold Spring Harbor Laboratory 2020
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7430623/
https://ncbi.nlm.nih.gov/pubmed/32817978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.08.12.20169359
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים